OXFORD PHARMAGENESIS HOLDINGS LIMITED
Get an alert when OXFORD PHARMAGENESIS HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£17M
+132.9% highest in 3 filed years
Net assets
£31M
+28.8% highest in 3 filed years
Employees
453
-8.7% lowest in 3 filed years
Profit before tax
£12M
+55.1% highest in 3 filed years
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-10-31
| Metric | Trend | 2023-10-31 | 2024-10-31 | 2025-10-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £60,610,424 | £55,393,300 | £57,056,272 | +3% | |
| Operating profit | £8,112,524 | £7,490,863 | £12,076,466 | +61.2% | |
| Profit before tax | £8,490,414 | £7,943,563 | £12,316,966 | +55.1% | |
| Net profit | £6,494,615 | £5,903,412 | £9,166,767 | +55.3% | |
| Cash | £9,177,311 | £7,477,023 | £17,414,195 | +132.9% | |
| Total assets less current liabilities | £31,138,486 | £24,467,179 | £31,326,037 | +28% | |
| Net assets | £30,595,475 | £23,988,411 | £30,895,450 | +28.8% | |
| Equity | £30,595,475 | £23,988,411 | £30,895,450 | +28.8% | |
| Average employees | 525 | 496 | 453 | -8.7% | |
| Wages | £33,884,637 | £31,042,374 | £27,001,495 | -13% | |
| Directors' remuneration | £755,740 | £798,536 | £707,136 | -11.4% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-10-31 | 2024-10-31 | 2025-10-31 |
|---|---|---|---|---|
| Operating margin | 13.4% | 13.5% | 21.2% | |
| Net margin | 10.7% | 10.7% | 16.1% | |
| Return on capital employed | 26.1% | 30.6% | 38.6% | |
| Gearing (liabilities / total assets) | — | 29.7% | 27.1% | |
| Current ratio | 3.86x | 2.86x | 3.30x | |
| Interest cover | — | 94.90x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- OXFORD PHARMAGENESIS HOLDINGS LIMITED 2013-07-18 → present
- MC499 LIMITED 2012-10-05 → 2013-07-18
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Shaw Gibbs (Audit) Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future, thus they continue to adopt the going concern basis of accounting in preparing these financial statements.”
Group structure
- OXFORD PHARMAGENESIS HOLDINGS LIMITED · parent
- Oxford PharmaGenesis AG 100%
- Oxford PharmaGenesis Inc 100%
- Oxford PharmaGenesis Limited 100%
- Oxford PharmaGenesis Pty Ltd 100%
Significant events
- “Anticipating increased client demand for global delivery capabilities and ways of working, we have formed trans-Atlantic teams, bringing together the management of our UK- and US-based teams under our global Business Directors.”
- “During the year ending 31 October 2025, UK emissions reduced by 156.3 tonnes CO2 equivalents compared with the previous year”
- “Subsequent to the year end, Oxford PharmaGenesis AG was dissolved.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| TUSTIAN, James Edward | Secretary | 2022-05-31 | — | — |
| WHITE, Richard, Dr | Director | 2012-10-05 | Jan 1975 | British |
| WINCHESTER, Christopher Charles, Dr | Director | 2012-10-05 | Jul 1971 | British |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COSTIGAN, Jeanette Mary | Director | 2012-10-05 | 2019-12-17 |
| HAYES, Nigel Thornton | Director | 2013-09-19 | 2017-11-30 |
| HILLMAN, Alison | Director | 2012-10-05 | 2021-10-26 |
| SHELTON, Graham Anthony Brian, Dr | Director | 2013-07-10 | 2024-10-24 |
| SHERIDAN, Andrew | Director | 2012-10-05 | 2022-05-05 |
| THOMAS, Christopher John | Director | 2013-09-19 | 2018-01-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr Christopher Charles Winchester | Individual | Shares 25–50%, Voting 25–50% | 2021-10-26 | Active |
| Dr Richard White | Individual | Shares 25–50%, Voting 25–50% | 2021-10-26 | Active |
Filing timeline
Last 20 of 102 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-10-11 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-17 | AA | accounts | Accounts with accounts type group | |
| 2025-10-17 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-08-28 | SH04 | capital | Capital sale or transfer treasury shares with date currency capital figure | |
| 2025-08-11 | SH04 | capital | Capital sale or transfer treasury shares with date currency capital figure | |
| 2025-05-09 | AA | accounts | Accounts with accounts type group | |
| 2024-12-06 | SH03 | capital | Capital return purchase own shares treasury capital date | |
| 2024-11-07 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-11 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-02 | SH04 | capital | Capital sale or transfer treasury shares with date currency capital figure | |
| 2024-07-10 | SH04 | capital | Capital sale or transfer treasury shares with date currency capital figure | |
| 2024-05-10 | AA | accounts | Accounts with accounts type group | |
| 2023-10-11 | RESOLUTIONS | resolution | Resolution | |
| 2023-10-10 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-10-10 | SH04 | capital | Capital sale or transfer treasury shares with date currency capital figure | |
| 2023-05-03 | AA | accounts | Accounts with accounts type group | |
| 2023-03-13 | CH01 | officers | Change person director company with change date | |
| 2023-03-13 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-03-13 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-11-14 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2022-11-14 | PSC01 | persons-with-significant-control | Notification of a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 5
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.